VIMOVO 500 mg/20 mg modified-release tablets
Authorisation PA2242/014/001 · Grunenthal Pharma Limited.
- Licence holder
- Grunenthal Pharma Limited. (all products →)
- Active substances
- Naproxen, Esomeprazole magnesium trihydrate
- Clinical trials
- 2 clinical trials → 18 clinical trials →
- Dosage form
- Modified-release tablet
- Route of administration
- Oral use
- ATC codes
- M01AE, M01AE52
- First authorised
- 21/12/2010
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Fixed combination application (Article 10b of Directive No 2001/83/EC)
Naproxen: supply and approvals
12 authorised products on the HPRA list contain Naproxen. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Esomeprazole magnesium trihydrate: supply and approvals
43 authorised products on the HPRA list contain Esomeprazole magnesium trihydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 15 years (since 21 December 2010). The HPRA list marks it as marketed in Ireland.
Other medicines with Naproxen in Ireland
10 other products on the HPRA list contain Naproxen, from 7 licence holders; 5 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Naprosyn EC 250mg Gastro-resistant Tablets | Atnahs Pharma Netherlands B.V. | National authorisation (PA) | Marketed |
| Naprosyn EC 500mg Gastro-resistant Tablets | Atnahs Pharma Netherlands B.V. | National authorisation (PA) | Marketed |
| Naproxen 250 mg Gastro-resistant Tablets | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Marketed |
| Naproxen 500 mg Gastro-resistant Tablets | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Marketed |
| Naproxen/Esomeprazole Rowex 500 mg/20 mg modified-release tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Naproxen/Esomeprazole Abdi 500 mg/20 mg Modified Release Tablets | Abdi Farma GmbH | National authorisation (PA) | Not marketed |
| Naproxen/Esomeprazole MSN 500 mg/20 mg modified-release tablets | MSN Labs Europe Limited | National authorisation (PA) | Not marketed |
| Naproxen/Esomeprazole Polpharma 500/20 mg Modified-release Tablets | Zaklady Farmaceutyczne Polpharma S.A. | National authorisation (PA) | Not marketed |
| Naproxen/Esomeprazole Rowex Ltd 500 mg/20 mg modified-release tablets | Rowex Limited, | National authorisation (PA) | Not marketed |
| VIMOVO 500 mg/20 mg modified-release tablets | Merit Pharmaceuticals Limited | Parallel import (PPA) | Not stated |
Other medicines with Esomeprazole magnesium trihydrate in Ireland
13 other products on the HPRA list contain Esomeprazole magnesium trihydrate, from 9 licence holders; 6 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Esomeprazole 40 mg powder for solution injection/infusion | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Esomeprazole Pinewood 20 mg gastro-resistant tablets | Pinewood Laboratories Limited | National authorisation (PA) | Marketed |
| Esomeprazole Pinewood 40 mg gastro-resistant tablets | Pinewood Laboratories Limited | National authorisation (PA) | Marketed |
| Naproxen/Esomeprazole Rowex 500 mg/20 mg modified-release tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Nexium 20 mg gastro-resistant tablets | Grunenthal Pharma Limited. | National authorisation (PA) | Marketed |
| Nexium 40 mg gastro-resistant tablets | Grunenthal Pharma Limited. | National authorisation (PA) | Marketed |
| Esomeprazole Clonmel 20 mg gastro-resistant tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Not marketed |
| Naproxen/Esomeprazole Abdi 500 mg/20 mg Modified Release Tablets | Abdi Farma GmbH | National authorisation (PA) | Not marketed |
| Naproxen/Esomeprazole MSN 500 mg/20 mg modified-release tablets | MSN Labs Europe Limited | National authorisation (PA) | Not marketed |
| Naproxen/Esomeprazole Polpharma 500/20 mg Modified-release Tablets | Zaklady Farmaceutyczne Polpharma S.A. | National authorisation (PA) | Not marketed |
| Naproxen/Esomeprazole Rowex Ltd 500 mg/20 mg modified-release tablets | Rowex Limited, | National authorisation (PA) | Not marketed |
| Nexium Control 20 mg gastro-resistant hard capsules | GlaxoSmithKline Dungarvan Limited | Centralised EU authorisation | Not stated |
Other substances in ATC group M01AE
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 6 other active substances share the group M01AE with this product:
Ibuprofen (49) · PSEUDOEPHEDRINE HYDROCHLORIDE (5) · Ibuprofen ph. eur. (4) · Dexketoprofen (3) · Dexketoprofen trometamol (2) · Ibuprofen lysinate (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Grunenthal Pharma Limited. holds 36 products on the HPRA list, with 17 different active substances; 34 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.